|
Online Database of Chemicals from Around the World | 产品搜索 | 产品提交 | 产品推广 |
网站主页 >> 化工产品目录 >> >> 市场分析报告 |
市场分析报告 |
|
Pruritus Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Pruritus Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pruritus - Drugs in Development by Stages, Target, MoA, RoA, ... Pruritus - Pipeline Insight, 2021 ... releases. Pruritus Emerging Drugs Difelikefalin: Cara Therapeutics Difelikefalin is a small peptide molecule ... Drug Application (NDA) for difelikefalin (Korsuva), for the treatment ... Akari Therapeutics Key Products Difelikefalin BLU-5937 Dupilumab M-5250 T ... Pruritis - Pipeline Insight, 2019 This report can be delivered to the clients within 24 Hours "Pruritis - Pipeline Insight, 2019" report by DelveInsight outlays comprehensive insights of present scenario and growth prospects across the indication. A detailed picture of the Pruritis ... Haemodialysis Machines- Market Insights, Competitive Landscape and Market Forecast–2027 ... : On February 23, 2022, the FDA approved Difelikefalin injection (Korsuva; Cara Therapeutics and ... Postoperative Pain Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 The 7 major postoperative pain markets reached a value of US$ 2,615.7 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 5,456.0 Million by 2034, exhibiting a growth rate (CAGR) of 6.91% during 2024-2034. The postoperative pain ... Pruritus Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 The 7 major pruritus markets reached a value of US$ 6.0 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 7.8 Billion by 2034, exhibiting a growth rate (CAGR) of 2.42% during 2024-2034. The pruritus market has been comprehensively ... |